Actively Recruiting

Phase Not Applicable
Age: 40Years - 80Years
All Genders
ID06942533

Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease

Led by General University Hospital, Prague · Updated on 2025-12-01

30

Participants Needed

2

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effect of visual feedback from the SpiroGym mobile application on expiratory muscle strength training (EMST) performance in patients with Parkinson's disease. This study uses a prospective crossover design to compare EMST sessions with and without the SpiroGym app, aiming to understand how real-time visual feedback influences muscle activation, expiratory performance, and participant motivation during training. Participants will complete two EMST sessions at 75% of their maximum expiratory pressure, separated by a two-week interval. One session includes visual feedback via the SpiroGym app, which shows a real-time curve of sound levels during exhalation to guide training effort. The other session is performed without this feedback. The order of sessions is randomized to compare effects within the same individual. During the study, researchers will measure muscle activation using surface electromyography (sEMG) of abdominal and suprahyoid muscles at baseline and after two weeks. The SpiroGym app will record sound intensity as a measure of expiratory effort. Participants will also complete a feedback questionnaire about difficulty and motivation. The study lasts for about two weeks per participant, with monitoring of exercise performance and subjective experience.

CONDITIONS

Brief Title

Effect of Visual Feedback From the SpiroGym Mobile Application

Who Can Participate

Age: 40Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Parkinsons disease
  • Stable dopaminergic medication (stable dose for at least 1 month)
  • Age between 40 and 80 years
Not Eligible

You will not qualify if you...

  • Other neurological disorders
  • Significant cognitive impairment
  • Major psychiatric disorder
  • History of head or neck cancer or previous surgical interventions in the neck region
  • Illness during the study period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Approximately 4 weeks

Participants complete two expiratory muscle strength training (EMST) sessions, one with visual feedback via the SpiroGym mobile application and one without. The order of sessions is randomly assigned, and sessions are separated by a two-week interval.

2 sessions spaced 2 weeks apart

Trial Site Locations

Total: 2 locations

1

General University Hospital

Prague, Czechia, 120 00

Actively Recruiting

2

Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague

Prague, Czechia, 16000

Actively Recruiting

Loading map...

Research Team

M

Martin Srp, Ph.D.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

10,000 STEP CLUB: Community Walking Program to Decrease Sede...

Parkinson Disease

Actively Recruiting

1 location

18F-DOPA II - PET Imaging Optimization

Congenital Hyperinsulinism

Actively Recruiting

1 location

24-month Open-label Study to Evaluate Safety, Tolerability, ...

Parkinson Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial